CAR-T
-
【药时代快讯】玛仕度肽临床研究结果顶刊发布；牛俊奇教授畅谈乙肝新药研发；全球医药CVC榜单出炉；央视发布甲状腺眼病纪录片《突破视界》；ADC进军新领域–减重。。。
每日发布，持续更新。欢迎广大朋友们关注，一起学习进步！
-
Breaking News! Legend Biotech’s CAR-T product “Ciltacabtagene Autoleucel” has been approved in China
Warmest congratulations to Legend Bio and JnJ!
-
Celine Dion, the legendary pop diva, is waiting for a CAR-T therapy?
All our best wishes! We will continue to provide our assistance to drug discovery and development with full effort
-
天后在等一个CAR-T疗法
01 天后 虽然巴黎奥运会已然落幕，但开幕典礼上的一幕，仍给众多观众留下深刻印象。 Celine Dion（席琳·迪翁）身着镶有流苏的白色串珠礼服，出现在埃菲尔铁塔脚下，当奥运圣火…
-
Who will acquire Legend Bio for 13B to 15B USD? Could it be J&J?
Will J&J be the buyer? Please share your thoughts!~
-
传奇生物确认收到并购邀约，股价大涨12%，市值近百亿美元，并购邀约引发市场关注
药时代将继续关注，及时报道。
-
Exchanging a CAR-T therapy for 18% of the shares, the decision-making of Innovent Biologics
All comments are highly welcome!
-
一款CAR-T 换 18%股份，信达生物的取舍
关注药时代，一起洞察行业，共创未来！
-
CAR-T Black Box Warning Controversy Again？
DrugTimes will follow this crucial matter and report timely
-
【ASCO Highlights】China-made First-in-Class Claudin 18.2 CAR-T Therapy Shows Promising Phase I Results!
Follow Drug Times to grasp valuable industry information at the first moment
